Tapinarof has not been studied during breastfeeding. Because it is poorly absorbed after topical application, it is considered a low risk to the nursing infant.[1] Do not apply tapinarof directly to the nipple and areola and ensure that the infant's skin does not come into direct contact with the areas of skin that have been treated.
他扎罗汀在哺乳期尚未进行研究。由于局部应用后吸收较差，因此认为对哺乳期婴儿风险较低。[1] 请勿将他扎罗汀直接涂抹于乳头和乳晕，并确保婴儿皮肤不与已治疗的皮肤区域直接接触。
